gp350-Ferritin Nanoparticle Vaccine

gp350-Ferritin nanoparticle EBV vaccine · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for gp350-Ferritin Nanoparticle Vaccine, covering 2026-07-22 to 2026-07-22. Get the full timeline:

Most recent: Clinical Trial Results: Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults [Phase 1]

See pricing